Situations where personal financial gain or loyalty may compromise objective decision-making, particularly in regulatory, medical, or governmental roles.
A conflict of interest occurs when an individual's private interests diverge from their professional obligations, creating incentive to act in ways that benefit themselves rather than the public they serve. In regulatory agencies, corporate boards, and healthcare systems, undisclosed conflicts have historically enabled decisions favoring private gain over public welfare. The problem intensifies when institutional frameworks fail to require transparency or recusal.
In 2004, FDA officials approved the arthritis drug Vioxx despite internal evidence of cardiovascular risks, partly because advisory committee members had financial ties to manufacturer Merck—some receiving consulting fees or research funding. The drug was linked to approximately 27,000 deaths before withdrawal. Similarly, in 2020, the CDC's guidance on lab safety protocols for COVID-19 virus origins faced credibility questions when key officials had undisclosed financial interests in gain-of-function research funding through NIH grants and academic partnerships, creating incentive to downplay lab-leak scenarios that might implicate their institutions.
